Leverone Jason A.
Chief Financial Officer
Leverone Jason A. has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 23, 2026.
On the most recent filing, Leverone Jason A. is listed as Chief Financial Officer at OnKure Therapeutics, Inc. Inside the rolling window, Leverone Jason A. reported no open-market purchases and 4 open-market sales totaling $4K in OKUR. The largest disclosed transaction in the window is a sale of 303 OKUR shares on Jun 22, 2026, worth $1K.
Companies traded
Other insiders at OKUR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 22, 2025 | OKUR | Sale | $795 |
Frequently asked questions
How many SEC Form 4 filings has Leverone Jason A. made?
Leverone Jason A. has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Leverone Jason A. trade?
Leverone Jason A. has filed SEC Form 4 disclosures for 1 company, including OKUR.
When was Leverone Jason A.'s most recent SEC Form 4 filing?
Leverone Jason A.'s most recent SEC Form 4 filing on Tracefour is dated Sep 23, 2026.
What is Leverone Jason A.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Leverone Jason A. is listed as Chief Financial Officer.
What is Leverone Jason A.'s total buy and sell value in the current window?
Inside the rolling retention window, Leverone Jason A. bought $0 and sold $4K based on SEC Form 4 filings.
What was Leverone Jason A.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 303 OKUR shares on 2026-06-22, worth $1K, per SEC Form 4 filings.